Marshall Wace, LLP Tandem Diabetes Care Inc Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 950,948 shares of TNDM stock, worth $21.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

950,948

Previous 813,594 16.88%

Holding current value

$21.1 Million

Previous $34.5 Million 0.7%

% of portfolio

0.04%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$27.34 - $41.78 $3.76 Million - $5.74 Million	137,354 Added 16.88%	950,948 $34.3 Million
Q3 2024 Nov 14, 2024	BUY	$35.21 - $47.3 $10.2 Million - $13.7 Million	289,201 Added 55.15%	813,594 $34.5 Million
Q2 2024 Aug 14, 2024	SELL	$30.43 - $53.43 $79 Million - $139 Million	-2,595,981 Reduced 83.19%	524,393 $21.1 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $61.2 Million - $98 Million	2,768,459 Added 786.68%	3,120,374 $110 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $2.47 Million - $5.36 Million	172,875 Added 96.56%	351,915 $10.4 Million
Q3 2023 Nov 14, 2023	SELL	$19.33 - $36.22 $9.24 Million - $17.3 Million	-478,121 Reduced 72.76%	179,040 $3.72 Million
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $15.9 Million - $27.9 Million	657,161 New	657,161 $16.1 Million
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $31.3 Million - $49.5 Million	881,307 New	881,307 $39.6 Million
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $1.31 Million - $3.04 Million	-24,703 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $5.67 Million - $8.36 Million	-55,673 Reduced 69.27%	24,703 $2.87 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $7.63 Million - $9.89 Million	64,572 Added 408.58%	80,376 $12.1 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $1.48 Million - $2.05 Million	15,804 New	15,804 $1.89 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $369,215 - $480,411	-4,795 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$81.28 - $104.34 $52,506 - $67,403	646 Added 15.57%	4,795 $424,000
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $793,497 - $1.12 Million	-9,184 Reduced 68.88%	4,149 $397,000
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $328,565 - $399,697	3,443 Added 34.81%	13,333 $1.51 Million
Q2 2020 Aug 13, 2020	BUY	$60.05 - $98.92 $593,894 - $978,318	9,890 New	9,890 $978,000
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $243,481 - $462,805	-5,140 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $182,395 - $244,395	-3,433 Reduced 40.04%	5,140 $306,000
Q3 2019 Nov 14, 2019	BUY	$57.11 - $73.3 $162,135 - $208,098	2,839 Added 49.51%	8,573 $506,000
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $311,986 - $411,127	5,734 New	5,734 $370,000
Q1 2019 May 14, 2019	SELL	$32.25 - $73.56 $474,042 - $1.08 Million	-14,699 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$28.45 - $40.65 $418,186 - $597,514	14,699 New	14,699 $558,000

Others Institutions Holding TNDM

# of Institutions

346

Shares Held

70.9M

Call Options Held

3.11M

Put Options Held

181K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.42B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Tandem Diabetes Care Inc Transaction History